399 related articles for article (PubMed ID: 35465692)
21. Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life.
Novakova SM; Staevska MT; Novakova PI; Yoncheva MD; Bratoycheva MS; Musurlieva NM; Tzekov VD; Nicolov DG
Health Qual Life Outcomes; 2017 Sep; 15(1):189. PubMed ID: 28962623
[TBL] [Abstract][Full Text] [Related]
22. House dust mite SCIT reduces asthma risk and significantly improves long-term rhinitis and asthma control-A RWE study.
Jutel M; Klimek L; Richter H; Brüggenjürgen B; Vogelberg C
Allergy; 2024 Apr; 79(4):1042-1051. PubMed ID: 38429981
[TBL] [Abstract][Full Text] [Related]
23. Semi-depot house-dust mite allergen extract for Chinese with allergic rhinitis and asthma.
Li X; Wang X; Lin X; Xu G; Tao Z; Jiang W; Cheng L; Guo Y; Lai H; Shen K
Am J Rhinol Allergy; 2016 May; 30(3):201-8. PubMed ID: 27216351
[TBL] [Abstract][Full Text] [Related]
24. House dust mite sublingual immunotherapy in allergic rhinitis.
Cho SW; Han DH; Kim JW; Kim DY; Rhee CS
Immunotherapy; 2018 Jun; 10(7):567-578. PubMed ID: 29562802
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of house dust mite sublingual tablet in the treatment of allergic rhinoconjunctivitis: A randomized trial in a pediatric population.
Okamoto Y; Fujieda S; Okano M; Hida H; Kakudo S; Masuyama K
Pediatr Allergy Immunol; 2019 Feb; 30(1):66-73. PubMed ID: 30281866
[TBL] [Abstract][Full Text] [Related]
26. 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis.
Demoly P; Okamoto Y; Yang WH; Devillier P; Bergmann KC
Expert Rev Clin Immunol; 2016 Nov; 12(11):1141-1151. PubMed ID: 27632814
[TBL] [Abstract][Full Text] [Related]
27. Clinical efficacy and immunological mechanisms of sublingual and subcutaneous immunotherapy in asthmatic/rhinitis children sensitized to house dust mite: an open randomized controlled trial.
Eifan AO; Akkoc T; Yildiz A; Keles S; Ozdemir C; Bahceciler NN; Barlan IB
Clin Exp Allergy; 2010 Jun; 40(6):922-32. PubMed ID: 20100188
[TBL] [Abstract][Full Text] [Related]
28. [Comparison study of subcutaneous immunotherapy and sublingual immunotherapy in patients with allergic rhinitis].
You SH; Qin XY; Xu C; Qiu X; Luan ZL; Jia HX; Wang HT
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 May; 30(9):689-693. PubMed ID: 29771014
[No Abstract] [Full Text] [Related]
29. Efficacy and safety of intratonsillar immunotherapy for allergic rhinitis: A randomized, double-blind, placebo-controlled clinical trial.
Zhang J; Yang X; Chen G; Hu J; He Y; Ma J; Ma Z; Chen H; Huang Y; Wu Q; Liu Y; Yu L; Zhang H; Lai H; Zhang J; Zhai J; Huang M; Zou Z; Tao A
Ann Allergy Asthma Immunol; 2024 Mar; 132(3):346-354.e1. PubMed ID: 37913839
[TBL] [Abstract][Full Text] [Related]
30. Cost-minimization analysis of sublingual immunotherapy versus subcutaneous immunotherapy for house dust mite respiratory allergic disease in Denmark.
Rønborg S; Johnsen CR; Theilgaard S; Winther A; Hahn-Pedersen J; Andreasen JN; Olsen J
J Med Econ; 2016 Aug; 19(8):735-41. PubMed ID: 26909663
[TBL] [Abstract][Full Text] [Related]
31. Long-Term Efficacy and Safety of Subcutaneous Immunotherapy in Monosensitized and Polysensitized Children With Allergic Rhinitis.
Yuan X; Xie S; Zhang H; Zhang J; Fan R; Jiang W; Xie Z
Otolaryngol Head Neck Surg; 2024 Mar; 170(3):919-927. PubMed ID: 38104318
[TBL] [Abstract][Full Text] [Related]
32. Safety Profile and Issues of Subcutaneous Immunotherapy in the Treatment of Children with Allergic Rhinitis.
Endaryanto A; Nugraha RA
Cells; 2022 May; 11(9):. PubMed ID: 35563890
[TBL] [Abstract][Full Text] [Related]
33. Clinical Response to Subcutaneous Dermatophagoides pteronyssinus Immunotherapy in Children with Allergic Rhinitis and Asthma Is Independent of Sensitization to Blomia tropicalis Allergens.
Chen S; Zheng Y; Chen B; Zhong H; Liao F; Wang L; Hui SF; Lai X
Int Arch Allergy Immunol; 2019; 178(2):201-210. PubMed ID: 30544116
[TBL] [Abstract][Full Text] [Related]
34. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites.
Song Y; Long J; Wang T; Xie J; Wang M; Tan G
J Laryngol Otol; 2018 Mar; 132(3):230-235. PubMed ID: 29374499
[TBL] [Abstract][Full Text] [Related]
35. Absence of IgE neosensitization in house dust mite allergic patients following sublingual immunotherapy.
Baron-Bodo V; Batard T; Nguyen H; Fréreux M; Horiot S; Harwanegg C; Bergmann KC; de Beaumont O; Moingeon P
Clin Exp Allergy; 2012 Oct; 42(10):1510-8. PubMed ID: 22994348
[TBL] [Abstract][Full Text] [Related]
36. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
37. SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis.
Meteran H; Backer V
Expert Rev Clin Immunol; 2019 Nov; 15(11):1127-1133. PubMed ID: 31584839
[No Abstract] [Full Text] [Related]
38. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
[TBL] [Abstract][Full Text] [Related]
39. A Three-Year Course of House Dust Mite Sublingual Immunotherapy Appears Effective in Controlling the Symptoms of Allergic Rhinitis.
Novakova SM; Novakova PI; Yakovliev PH; Staevska MT; Mateva NG; Dimcheva TD; Peichev JL
Am J Rhinol Allergy; 2018 May; 32(3):147-152. PubMed ID: 29649893
[TBL] [Abstract][Full Text] [Related]
40. Switching from subcutaneous to sublingual immunotherapy during the maintenance phase in patients with house dust mite allergy.
Kiatiwat P; Sangasapaviliya A; Pradubpongsa P; Sangkanjanavanich S; Chiewchalermsri C; Jacquet A; Jaisupa N; Jindarat S; Boonpiyathad T; Mitthamsiri W
Allergy; 2023 Jul; 78(7):2019-2021. PubMed ID: 36754574
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
